• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

RCT: No value in computerized CBT for Depression (including R Morris)

Esther12

Senior Member
Messages
13,774
Not that interesting, but I wonder if this sort of internet based intervention is, when an alternative is provided, quite a good way of controlling for response bias, and testing the actual value of the CBT model.

http://journals.cambridge.org/actio...3647&fulltextType=RA&fileId=S0033291713001323
Randomized controlled trial of computerized cognitive behavioural therapy for depressive symptoms: effectiveness and costs of a workplace intervention

R. Phillipsa1, J. Schneidera2 c1, I. Molosankwea1, M. Leesea1, P. Sarrami Foroushania3, P. Grimea4, P. McCronea1, R. Morrissa2 and G. Thornicrofta1

a1 Institute of Psychiatry, King's College London, London, UK
a2 Institute of Mental Health, University of Nottingham, Nottingham, UK
a3 University of New South Wales, Sydney, NSW, Australia
a4 Cambridge University Hospital NHS Foundation Trust, Cambridge, UK
Abstract
Background Depression and anxiety are major causes of absence from work and underperformance in the workplace. Cognitive behavioural therapy (CBT) can be effective in treating such problems and online versions offer many practical advantages. The aim of the study was to investigate the effectiveness of a computerized CBT intervention (MoodGYM) in a workplace context.
Method The study was a phase III two-arm, parallel randomized controlled trial whose main outcome was total score on the Work and Social Adjustment Scale (WSAS). Depression, anxiety, psychological functioning, costs and acceptability of the online process were also measured. Most data were collected online for 637 participants at baseline, 359 at 6 weeks marking the end of the intervention and 251 participants at 12 weeks post-baseline.
Results In both experimental and control groups depression scores improved over 6 weeks but attrition was high. There was no evidence for a difference in the average treatment effect of MoodGYM on the WSAS, nor for a difference in any of the secondary outcomes.
Conclusions This study found no evidence that MoodGYM was superior to informational websites in terms of psychological outcomes or service use, although improvement to subthreshold levels of depression was seen in nearly half the patients in both groups.
(Received December 04 2012)
(Revised April 25 2013)
(Accepted May 10 2013)